EPISODE · May 6, 2026 · 1 MIN
Novo Nordisk Crushes Q1, Wegovy Pill Sales Soar
from The Daily News Now! Business
Novo Nordisk soars with record-breaking first-quarter sales, driven by their new oral weight-loss pill, Wegovy, which exceeded expectations by doubling forecasts. The company raised its annual profit outlook, with obesity care lineup sales surging twenty-two percent. Despite a slight dip in diabetes staple Ozempic sales, Novo Nordisk remains a strong contender in the weight-loss market. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ac4efceb6f07d3f4
NOW PLAYING
Novo Nordisk Crushes Q1, Wegovy Pill Sales Soar
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m